THE SCHEDULE 13G

Company

GYRE THERAPEUTICS, INC.

Filed

March 1, 2019

Accession Number

0000921895-19-000615

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →